Ghost Tree Capital’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Ghost Tree Capital’s Portfolio VTAE Stock Details VTAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-101,188	Closed	-$671K	–	89
2016 Q1	$671K	Sell	101,188 -173,812	-63%	-$1.58M	0.38%	45
2015 Q4	$4.98M	Buy	275,000 +25,000	+10%	+$344K	2.04%	22
2015 Q3	$2.75M	Sell	250,000 -39,200	-14%	-$417K	1.24%	34
2015 Q2	$4.16M	Sell	289,200 -10,800	-4%	-$147K	1.35%	35
2015 Q1	$3.51M	Buy	+300,000	New	+$4.05M	1.26%	40

Other funds holding VTAE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Ghost Tree Capital's VTAE Position: Q2 2016 in Review

Ghost Tree Capital sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q2 2016, closing a stake of 101,188 shares — an estimated $671K sold.

Ghost Tree Capital first reported a position in VTAE in Q1 2015 and held it in 5 quarters. The position peaked at $4.98M in Q4 2015. 71 funds tracked by Wall St. Rank hold VTAE as of Q2 2016.

Ghost Tree Capital reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q2 2016 after selling out during the quarter.
Ghost Tree Capital sold 101,188 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q2 2016, an estimated $671K.
Ghost Tree Capital first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q1 2015 and held it in 5 quarters.
Ghost Tree Capital's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $4.98M in Q4 2015.
71 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q2 2016.

Based on Ghost Tree Capital's 13F filing for Q2 2016, filed 12 Aug 2016.